Characterization of critical determinants of ACE2–SARS CoV-2 RBD interaction EEF Brown, R Rezaei, TR Jamieson, J Dave, NT Martin, R Singaravelu, ... International Journal of Molecular Sciences 22 (5), 2268, 2021 | 36 | 2021 |
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ... Molecular Therapy 29 (6), 1984-2000, 2021 | 26 | 2021 |
Implications for SARS-CoV-2 vaccine design: Fusion of spike glycoprotein transmembrane domain to receptor-binding domain induces trimerization T Azad, R Singaravelu, MJF Crupi, T Jamieson, J Dave, EEF Brown, ... Membranes 10 (9), 215, 2020 | 25 | 2020 |
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy ME Wedge, VA Jennings, MJF Crupi, J Poutou, T Jamieson, A Pelin, ... Nature communications 13 (1), 1898, 2022 | 23 | 2022 |
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection S Boulton, J Poutou, NT Martin, T Azad, R Singaravelu, MJF Crupi, ... Molecular Therapy 30 (5), 1885-1896, 2022 | 19 | 2022 |
Characterization of Proteobacterial Plasmid Integron-Encoded qac Efflux Pump Sequence Diversity and Quaternary Ammonium Compound Antiseptic Selection in … CJ Slipski, TR Jamieson-Datzkiw, GG Zhanel, DC Bay Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 01069-21, 2021 | 13 | 2021 |
A high-throughput NanoBiT-based serological assay detects SARS-CoV-2 seroconversion T Azad, R Rezaei, R Singaravelu, TR Jamieson, MJF Crupi, A Surendran, ... Nanomaterials 11 (3), 807, 2021 | 12 | 2021 |
Riboswitch-associated guanidinium-selective efflux pumps frequently transmitted on proteobacterial plasmids increase Escherichia coli biofilm tolerance to disinfectants CJ Slipski, TR Jamieson, GG Zhanel, DC Bay Journal of bacteriology 202 (23), 10.1128/jb. 00104-20, 2020 | 11 | 2020 |
Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment TR Jamieson, J Poutou, CS Ilkow Cytokine & Growth Factor Reviews 56, 102-114, 2020 | 9 | 2020 |
Plasmid transmitted small multidrug resistant (SMR) efflux pumps differ in gene regulation and enhance tolerance to quaternary ammonium compounds (QAC) when grown as biofilms CJ Slipski, TR Jamieson, A Lam, VL Shing, K Bell, GG Zhanel, DC Bay BioRxiv, 768630, 2019 | 8 | 2019 |
Detection of SARS-CoV-2 receptor-binding domain antibody using a HiBiT-based bioreporter R Rezaei, A Surendran, R Singaravelu, TR Jamieson, P Taklifi, J Poutou, ... JoVE (Journal of Visualized Experiments), e62488, 2021 | 2 | 2021 |
AT cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection S Boulton, J Poutou, R Gill, N Alluqmani, X He, R Singaravelu, MJF Crupi, ... Molecular Therapy-Methods & Clinical Development 31, 2023 | 1 | 2023 |
Optimal delivery of RNA interference by viral vectors for cancer therapy B Wong, R Birtch, R Rezaei, T Jamieson, MJF Crupi, JS Diallo, CS Ilkow Molecular Therapy 31 (11), 3127-3145, 2023 | 1 | 2023 |
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development S Boulton, MJF Crupi, S Singh, ME Carter-Timofte, T Azad, BC Organ, ... Journal of Biological Chemistry 299 (6), 2023 | | 2023 |
Arming Vesiculovirus with SARS-CoV2 Spike Protein Creates a Murine Model of Severe COVID-19 ARDS A Tieu, D Chwastek, C Lansdell, T Jamieson, C Ilkow, D Stewart, M Lalu D17. TOP KNOWLEDGE IN COVID, A5054-A5054, 2022 | | 2022 |
17: ARMING VESICULOVIRUS WITH SARS-COV-2 S-PROTEIN CREATES A MURINE MODEL OF SEVERE COVID-19 ARDS A Tieu, D Chwastek, L Casey, T Jamieson, I Carolina, D Stewart, M Lalu Critical Care Medicine 50 (1), 9, 2022 | | 2022 |
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection TR Jamieson, J Poutou, R Marius, X He, R Rezaei, T Azad, CS Ilkow JoVE (Journal of Visualized Experiments), e62486, 2021 | | 2021 |
Characterization of Critical Determinants of ACE2-RBD Interaction EEF Brown, R Rezaei, T Jamieson, J Dave, NT Martin, R Singaravelu, ... bioRxiv, 2021.01. 29.428773, 2021 | | 2021 |
Characterization of Critical Determinants of ACE2-RBD Interaction (preprint) E Brown, R Rezaei, T Jamieson, J Dave, N Martin, R Singaravelu, ... | | 2021 |
Nanoluciferase complementation-based biosensor reveals the importance of N-linked glycosylation of SARS-CoV-2 Spike for viral entry (preprint) T Azad, R Singaravelu, Z Taha, S Boulton, MJF Crupi, NT Martin, ... | | 2020 |